CHMP recommends Humira(Abbott) for Ulcerative Colitis

The CHMP gives a positive opinion to expand the label on Humira (adalimumab) from Abbott Labs to include the treatment of adults with moderate to severely active Ulcerative Colitis for whom conventional therapies are not suitable. If the European Commission acts on the advice, Humira will be the first self-injectable biologic therapy available for those Ulcerative Colitis patients.